NDC product
hydrocortisone acetate pramoxine HCl
NDC 45802-124 · Padagis Israel Pharmaceuticals Ltd
Key facts
| Product NDC | 45802-124 |
|---|---|
| Proprietary name | hydrocortisone acetate pramoxine HCl |
| Nonproprietary name | Hydrocortisone Acetate, Pramoxine HCl |
| Substances | HYDROCORTISONE ACETATE, PRAMOXINE HYDROCHLORIDE |
| Dosage form | CREAM |
| Route | TOPICAL |
| Labeler | Padagis Israel Pharmaceuticals Ltd |
| Product type | HUMAN PRESCRIPTION DRUG |
| Marketing category | UNAPPROVED DRUG OTHER |
| Pharmacologic classes | Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC] |
| Marketing start | Mar 29, 2011 |
| Listing certified through | Dec 31, 2026 |
At a glance
- 1–9 Package NDCs
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About National Drug Codes (NDC)
The National Drug Code (NDC) is the FDA's product identifier for drugs; the product NDC identifies the labeler and product, and each package adds a package code.
Source: U.S. Food and Drug Administration (FDA), National Drug Code Directory · Source date: